Showing Results for
- Academic Journals (51)
Search Results
- 51
Academic Journals
- 51
- Search Terms:
- 1From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedTo the Editor: In his News Feature published in the February issue, Michael Eisenstein outlines several alternative methods of drug delivery (1) and discusses how several targets in the central nervous system "remain...
- 2From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedLate-stage trial results for Pfizer's first-in-class small-molecule Janus kinase (JAK) inhibitor tofacitinib in rheumatoid arthritis have raised expectations for regulatory approval as early as next year. All five...
- 3From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedTo the Editor: Zhao and Stormo (1) introduce a new method for deriving position weight matrices (PWMs) from protein binding microarrays (BEEML-PBM). Using this method, they challenge a central claim of our 2009 paper...
- 4From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedUganda has launched field trials of its own genetically modified (GM) bananas in an effort to counter a disease that is devastating plantations in the Great Lakes region of Africa. The GM bananas are genetically...
- 5From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedMucosis (Groningen, The Netherlands) has named Thomas Johnston as chief business officer. He joins the company from Novavax, where he was vice president of strategy. Before going to Novavax, Johnston served as an...
- 6From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedThe search for cleverer ways of making induced pluripotent stem cells (iPSCs) has chalked up another remarkable success with a recent paper by Morrisey and colleagues (1) in Cell Stem Cell. The new strategy, which is...
- 7From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedIn a lawsuit over genetically modified (GM) modified rice, jury members in an Arkansas circuit court ruled in March in favor of Riceland Foods of Stuttgart, Arkansas, a rice milling and exporting company, and against...
- 8From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedThis issue marks the publication of the whole genome sequence of the date palm (Phoenix dactylifera), an economically important crop whose fruit is a staple in many Middle Eastern and North African nations. By...
- 9From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedImmune responses targeting self-proteins (autoantigens) can lead to a variety of autoimmune diseases. Identification of these antigens is important for both diagnostic and therapeutic reasons. However, current...
- 10From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedFarzad (Zod) Nazem (left) has been named to the to board of directors of platform company NextBio (Cupertino, CA, USA). Nazem served as chief technology officer at Yahoo! from 1996 until his retirement in 2007....
- 11From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedDate palm is one of the most economically important woody crops cultivated in the Middle East and North Africa and is a good candidate for improving agricultural yields in arid environments. Nonetheless, long generation...
- 12From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedTo the Editor: Although scientifically promising, research using human embryonic stem cells (hESCs) has roused political controversy for nearly two decades, with sharp differences between policies in different...
- 13From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-Reviewed"My goal as CEO is never to inaugurate a new research and development center." Sanofi CEO Chris Viehbacher comments on the French pharma's new strategy of co-investing in early-stage biotechs. (Boston Business Journal,...
- 14From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedActivaero (Gemunden (Wohra), Germany) has appointed Christian M. Pangratz chief business officer, replacing Henrik Luessen. Pangratz joins the company from Nektar Therapeutics where he served as executive director of...
- 15From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedNearly 10% of the 1,541 drugs approved by the US Food and Drug Administration (FDA) since 1990 have their roots in public sector research according to a paper published earlier this year in the New England Journal of...
- 16From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedTo the Editor: Determining the specificity of transcription factors is an important step in understanding regulatory networks and the effects of genetic variations on those networks. To date, attempts to use position...
- 17From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedLiver transplantation is the only remedy for liver failure, but many people in need of a transplant die awaiting a donor. Whereas stem cells of various kinds can be coaxed to form hepatocytes, the protocols are involved...
- 18From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedChina has passed the World Health Organization (WHO)'s vaccine regulatory assessment, an approval that gives local manufacturers a green light to enter the global vaccine market. On March 1, WHO stated that Chinas State...
- 19From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedHuman pluripotent stem cells (hPSCs) have been differentiated efficiently to neuronal cell types. However, directed differentiation of hPSCs to astrocytes and astroglial subtypes remains elusive. In this study, hPSCs...
- 20From: Nature Biotechnology. (Vol. 29, Issue 6) Peer-ReviewedPersonalized cancer diagnostics company Foundation Medicine (Cambridge, MA, USA) has announced the appointment of Michael J. Pellini (left) as president and CEO. He succeeds founding CEO Alexis Borisy, who will remain...